| 1 |
35460083 | Pharmacology, safety, efficacy and clinical uses of the COX-2 inhibitor robenacoxib. | 2022 Apr 22 |
3 |
| 2 |
27493016 | Evaluation of the dose-response relationship of oral robenacoxib in urate crystal-induced acute stifle synovitis in dogs. | 2017 Apr |
2 |
| 3 |
28651573 | Efficacy and safety of oral robenacoxib (tablet) for the treatment of pain associated with soft tissue surgery in client-owned dogs. | 2017 Jun 26 |
1 |
| 4 |
23452411 | The effect of robenacoxib on the concentration of C-reactive protein in synovial fluid from dogs with osteoarthritis. | 2013 Mar 1 |
1 |
| 5 |
23638669 | Robenacoxib versus meloxicam for the management of pain and inflammation associated with soft tissue surgery in dogs: a randomized, non-inferiority clinical trial. | 2013 May 2 |
1 |
| 6 |
21480932 | Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial. | 2012 Apr |
1 |
| 7 |
21492194 | Robenacoxib in the dog: target species safety in relation to extent and duration of inhibition of COX-1 and COX-2. | 2011 Jun |
4 |
| 8 |
20004922 | In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study. | 2010 Jun |
7 |
| 9 |
20444036 | Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog. | 2010 Apr |
2 |